Tag: Lems

Affecting approximately 1 in 100,000 people worldwide, Lambert-Eaton Myasthenic Syndrome (LEMS) is a rare autoimmune disorder. The key question for patients is: **What is the FDA treatment for Lambert-Eaton?** The answer is a medication called amifampridine.

In 2018, the U.S. Food and Drug Administration (FDA) approved the first and only evidence-based medication specifically for adults with Lambert-Eaton Myasthenic Syndrome (LEMS). For patients wondering what is the new treatment for LEMS, the primary focus has been on this prescription drug, amifampridine (Firdapse), along with established immunomodulatory strategies and treatment for any associated cancers.